UPDATE: HIV in Arkansas: Key Policy Issues

December 16, 2022


Jennifer Wessel, JD, MPH
Senior Policy Analyst and Data Privacy Officer

  • Subscribe for Updates

There has been significant progress in preventing and treating infections caused by human immunodeficiency virus (HIV), but the virus remains a persistent problem in Arkansas and across the nation. Our updated explainer discusses several strategies to reduce new HIV infections in the United States: treatment as prevention, pre-exposure prophylaxis (PrEP), post-exposure prophylaxis (PEP), syringe service programs, and decriminalization of HIV. It also highlights potential changes in Arkansas policy, including a bill introduced in November 2022 that would authorize pharmacists to dispense both PrEP and PEP under a statewide protocol.

    Skip to content